These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 3470395

  • 1. Effects of recombinant human tumor necrosis factor (rhTNF) on normal human and mouse hemopoietic progenitor cells.
    Akahane K, Hosoi T, Urabe A, Kawakami M, Takaku F.
    Int J Cell Cloning; 1987 Jan; 5(1):16-26. PubMed ID: 3470395
    [Abstract] [Full Text] [Related]

  • 2. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D, Strife A, Atzpodien J, Clarkson BD.
    Cancer Res; 1987 Sep 15; 47(18):4788-94. PubMed ID: 3040231
    [Abstract] [Full Text] [Related]

  • 3. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
    Broxmeyer HE, Williams DE, Lu L, Cooper S, Anderson SL, Beyer GS, Hoffman R, Rubin BY.
    J Immunol; 1986 Jun 15; 136(12):4487-95. PubMed ID: 3086433
    [Abstract] [Full Text] [Related]

  • 4. Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells.
    Roodman GD, Bird A, Hutzler D, Montgomery W.
    Exp Hematol; 1987 Oct 15; 15(9):928-35. PubMed ID: 2820776
    [Abstract] [Full Text] [Related]

  • 5. Suppressive biological activity of a synthetic pentapeptide on highly enriched human and murine marrow hematopoietic progenitors: synergism with recombinant human tumor necrosis factor-alpha and interferon-gamma.
    Lu L, Foa P, Chillemi F, Shen RN, Lin ZH, Carow C, Broxmeyer HE.
    Exp Hematol; 1989 Oct 15; 17(9):935-41. PubMed ID: 2506072
    [Abstract] [Full Text] [Related]

  • 6. Characterization of adult human marrow hematopoietic progenitors highly enriched by two-color cell sorting with My10 and major histocompatibility class II monoclonal antibodies.
    Lu L, Walker D, Broxmeyer HE, Hoffman R, Hu W, Walker E.
    J Immunol; 1987 Sep 15; 139(6):1823-9. PubMed ID: 3114377
    [Abstract] [Full Text] [Related]

  • 7. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells.
    Broxmeyer HE, Lu L, Platzer E, Feit C, Juliano L, Rubin BY.
    J Immunol; 1983 Sep 15; 131(3):1300-5. PubMed ID: 6193183
    [Abstract] [Full Text] [Related]

  • 8. Effect of deoxycytidine on 2-chloro-deoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells.
    Bilgeri R, Petzer AL, Zilian U, Geisen FH, Schirmer M, Haun M, Konwalinka G.
    Exp Hematol; 1993 Mar 15; 21(3):432-7. PubMed ID: 8095026
    [Abstract] [Full Text] [Related]

  • 9. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM, Fortuna A, Fogli M, Motta MR, Rizzi S, Benini C, Tura S.
    Exp Hematol; 1994 Aug 15; 22(9):919-23. PubMed ID: 7520394
    [Abstract] [Full Text] [Related]

  • 10. The opposing actions in vivo on murine myelopoiesis of purified preparations of lactoferrin and the colony stimulating factors.
    Broxmeyer HE, Williams DE, Hangoc G, Cooper S, Gentile P, Shen RN, Ralph P, Gillis S, Bicknell DC.
    Blood Cells; 1987 Aug 15; 13(1-2):31-48. PubMed ID: 3499193
    [Abstract] [Full Text] [Related]

  • 11. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec 15; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 12. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM, Gulati SC.
    Stem Cells; 1993 Sep 15; 11(5):435-44. PubMed ID: 7694721
    [Abstract] [Full Text] [Related]

  • 13. Interaction of transforming growth factor-beta 1 with hemopoietic growth factors in the regulation of human normal and leukemic myelopoiesis.
    Aglietta M, Stacchini A, Severino A, Sanavio F, Ferrando ML, Piacibello W.
    Exp Hematol; 1989 Mar 15; 17(3):296-9. PubMed ID: 2783914
    [Abstract] [Full Text] [Related]

  • 14. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
    McCrady CW, Li F, Pettit GR, Grant S.
    Exp Hematol; 1993 Jul 15; 21(7):893-900. PubMed ID: 7686503
    [Abstract] [Full Text] [Related]

  • 15. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide.
    Ratajczak MZ, Ratajczak J, Kuczynski W, Light B, Lusk EJ, Gewirtz AM.
    Exp Hematol; 1993 Dec 15; 21(13):1663-7. PubMed ID: 8243568
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of human bone marrow-derived stem cell colony formation (CFU-E, BFU-E, and CFU-GM) following in vitro exposure to organophosphates.
    Gallicchio VS, Casale GP, Watts T.
    Exp Hematol; 1987 Dec 15; 15(11):1099-102. PubMed ID: 3678410
    [Abstract] [Full Text] [Related]

  • 17. Comparison of in vitro inhibition of etoposide (VP16) on leukemic and normal myeloid, erythroid clonogenic cells.
    Lagneaux L, Marie JP, Delforge A, Socquet M, Thevenin D, Zittoun R, Stryckmans P.
    Exp Hematol; 1989 Aug 15; 17(7):843-6. PubMed ID: 2753092
    [Abstract] [Full Text] [Related]

  • 18. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
    Carlo-Stella C, Mangoni L, Almici C, Caramatti C, Rizzoli V.
    Stem Cells; 1993 Jul 15; 11 Suppl 2():170-4. PubMed ID: 7691323
    [Abstract] [Full Text] [Related]

  • 19. Effects of recombinant interferons on the clonogenic growth of leukemic cells and normal hemopoietic progenitors.
    Hosoi T, Ozawa K, Urabe A, Takaku F.
    Int J Cell Cloning; 1985 Sep 15; 3(5):304-12. PubMed ID: 3930631
    [Abstract] [Full Text] [Related]

  • 20. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro.
    Maze R, Horie M, Hendrie P, Vadhan-Raj S, Tricot G, Gordon M, Nemunaitis J, Ashman LK, Broxmeyer HE.
    Exp Hematol; 1993 Apr 15; 21(4):545-51. PubMed ID: 7681784
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.